<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02615210</url>
  </required_header>
  <id_info>
    <org_study_id>23154</org_study_id>
    <nct_id>NCT02615210</nct_id>
  </id_info>
  <brief_title>Mid-Atlantic Research Group Single-Operator Cholangioscopic Assessment of Biliary Strictures</brief_title>
  <acronym>SOCABS</acronym>
  <official_title>Mid-Atlantic Research Group Single-Operator Cholangioscopic Assessment of Biliary Strictures</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Temple University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Thomas Jefferson University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Pennsylvania</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Pittsburgh</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Geisinger Clinic</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>McGill University Health Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Temple University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine if cholangioscopically-directed biopsies provide a
      higher diagnostic yield for malignancy in the setting of indeterminate biliary strictures
      when compared to standard means of sampling.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Biliary strictures in the absence of a mass are a clinical challenge, as current accepted
      means of sampling provide suboptimal accuracy. Both biliary brushings for cytology and
      fluoroscopically-directed biopsies produce highly-variable results. Endoscopic ultrasound
      with fine-needle aspiration has also been employed with variable results. An additional
      modality, using a single-operator cholangioscope during endoscopic retrograde
      cholangiopancreatography (ERCP) to obtain cholangioscopically-directed biopsies offers
      promise in increasing the yield of sampling. Initial observational studies have shown an
      improved diagnostic yield, but the technique has not been tested in a randomized, medical
      effectiveness study to better characterize its actual clinical impact. We aim to compare the
      technique of biopsy-on-biopsy derived sampling via single-operator cholangioscopy with
      standard fluoroscopically-directed biopsies and brushings in a pilot study. We also aim to
      perform a medical effectiveness study on the early use of single-operator cholangioscopically
      (SOC) in the evaluation of undiagnosed biliary strictures.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>November 2015</start_date>
  <completion_date type="Anticipated">November 2018</completion_date>
  <primary_completion_date type="Anticipated">November 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of malignant diagnoses across hree-sample techniques (Spy bite, forceps biopsy, brushings)</measure>
    <time_frame>72 Hours</time_frame>
    <description>Accuracy, sensitivity, and specificity of the three-sample technique (Spy bite, forceps biopsy, brushings) compared to the two-sample technique (forceps biopsy and brushing) in differentiating malignant from benign biliary strictures</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of patients who receive additional diagnostic studies without receiving a cancer diagnosis</measure>
    <time_frame>1 year</time_frame>
    <description>Patients who receive a repeat ERCP with sampling, cross-sectional imaging, EUS-FNA, IR-guided biopsies, laparoscopy</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Endoscopic Satisfaction with SOC-directed biopsy</measure>
    <time_frame>2 hours</time_frame>
    <description>Endoscopist subjective outcomes using a Likert scale 1-5
Ease of obtaining the biopsies
Confidence that the biopsy was taken from the target lesion
Confidence that an adequate sample was obtained from the biopsy
Clinical impression of malignant disease</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time from procedure to the initiation of treatment (in cases of malignancy)</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Biliary Tract Neoplasms</condition>
  <arm_group>
    <arm_group_label>Standard</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Standard of care biopsies with optional SOC-directed biopsy afterwards</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Study</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>SOC-directed biopsies using the SpyGlass System plus standard of care biopsies</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>SOC-directed biopsies using the SpyGlass System</intervention_name>
    <description>The cholangioscopy procedure with the SpyGlass System is performed by a single operator with the SpyScope Access and Delivery Catheter positioned just below the operating channel of the duodenoscope. SpyBite Biopsy Forceps guided by the SpyScope Catheter are introduced and endoscopic-guided biopsy is taken at the level of the stricture. Target lesions will be identified under direct visualization using the SOC system, and 6-8 bites will be performed with the SpyBite forceps. Once SOC-directed biopsies are obtained, the SOC system will be withdrawn into the working channel of the duodenoscope and removed Patient will be contacted monthly to determine if they have undergone any additional procedures and to record potential adverse events.</description>
    <arm_group_label>Study</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age greater than or equal to 18 years

          -  Presence of indeterminate biliary strictures with clinical indications for ERCP.
             Strictures are considered indeterminate when evaluation including cross-sectional
             imaging is non-diagnostic. Patients who have previously undergone ERCP with sampling
             will be included, as well as those who have not previously undergone ERCP.

          -  Strictures located above the intrapancreatic bile duct

          -  The Subject's physician determines and ERCP is clinically indicated

          -  Able to provide informed consent

        Exclusion Criteria:

          -  Prior enrollment in the study or another study evaluating biliary strictures

          -  Presence of extrahepatic malignancy or previously-diagnosed hepatocellular carcinoma

          -  Pregnancy

          -  At-risk populations including prisoners and mentally challenged

          -  Unwilling to provide informed consent

          -  Medically unfit to undergo ERCP

          -  History of liver transplant
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jennifre L Maranki, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Temple University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jennifer Maranki, M.D.</last_name>
    <phone>215-707-9523</phone>
    <email>jennifer.maranki@tuhs.temple.edu</email>
  </overall_contact>
  <reference>
    <citation>Lee JG, Leung JW, Baillie J, Layfield LJ, Cotton PB. Benign, dysplastic, or malignant--making sense of endoscopic bile duct brush cytology: results in 149 consecutive patients. Am J Gastroenterol. 1995 May;90(5):722-6.</citation>
    <PMID>7733076</PMID>
  </reference>
  <reference>
    <citation>Glasbrenner B, Ardan M, Boeck W, Preclik G, Möller P, Adler G. Prospective evaluation of brush cytology of biliary strictures during endoscopic retrograde cholangiopancreatography. Endoscopy. 1999 Nov;31(9):712-7.</citation>
    <PMID>10604612</PMID>
  </reference>
  <reference>
    <citation>Kipp BR, Stadheim LM, Halling SA, Pochron NL, Harmsen S, Nagorney DM, Sebo TJ, Therneau TM, Gores GJ, de Groen PC, Baron TH, Levy MJ, Halling KC, Roberts LR. A comparison of routine cytology and fluorescence in situ hybridization for the detection of malignant bile duct strictures. Am J Gastroenterol. 2004 Sep;99(9):1675-81.</citation>
    <PMID>15330900</PMID>
  </reference>
  <reference>
    <citation>Coté GA, Sherman S. Biliary stricture and negative cytology: what next? Clin Gastroenterol Hepatol. 2011 Sep;9(9):739-43. doi: 10.1016/j.cgh.2011.04.011. Epub 2011 Apr 22.</citation>
    <PMID>21554986</PMID>
  </reference>
  <reference>
    <citation>Draganov PV, Chauhan S, Wagh MS, Gupte AR, Lin T, Hou W, Forsmark CE. Diagnostic accuracy of conventional and cholangioscopy-guided sampling of indeterminate biliary lesions at the time of ERCP: a prospective, long-term follow-up study. Gastrointest Endosc. 2012 Feb;75(2):347-53. doi: 10.1016/j.gie.2011.09.020.</citation>
    <PMID>22248602</PMID>
  </reference>
  <reference>
    <citation>de Bellis M, Fogel EL, Sherman S, Watkins JL, Chappo J, Younger C, Cramer H, Lehman GA. Influence of stricture dilation and repeat brushing on the cancer detection rate of brush cytology in the evaluation of malignant biliary obstruction. Gastrointest Endosc. 2003 Aug;58(2):176-82.</citation>
    <PMID>12872082</PMID>
  </reference>
  <reference>
    <citation>Fogel EL, deBellis M, McHenry L, Watkins JL, Chappo J, Cramer H, Schmidt S, Lazzell-Pannell L, Sherman S, Lehman GA. Effectiveness of a new long cytology brush in the evaluation of malignant biliary obstruction: a prospective study. Gastrointest Endosc. 2006 Jan;63(1):71-7.</citation>
    <PMID>16377319</PMID>
  </reference>
  <reference>
    <citation>de Bellis M, Sherman S, Fogel EL, Cramer H, Chappo J, McHenry L Jr, Watkins JL, Lehman GA. Tissue sampling at ERCP in suspected malignant biliary strictures (Part 2). Gastrointest Endosc. 2002 Nov;56(5):720-30. Review.</citation>
    <PMID>12397282</PMID>
  </reference>
  <reference>
    <citation>De Bellis M, Sherman S, Fogel EL, Cramer H, Chappo J, McHenry L Jr, Watkins JL, Lehman GA. Tissue sampling at ERCP in suspected malignant biliary strictures (Part 1). Gastrointest Endosc. 2002 Oct;56(4):552-61. Review.</citation>
    <PMID>12297773</PMID>
  </reference>
  <reference>
    <citation>Weilert F, Bhat YM, Binmoeller KF, Kane S, Jaffee IM, Shaw RE, Cameron R, Hashimoto Y, Shah JN. EUS-FNA is superior to ERCP-based tissue sampling in suspected malignant biliary obstruction: results of a prospective, single-blind, comparative study. Gastrointest Endosc. 2014 Jul;80(1):97-104. doi: 10.1016/j.gie.2013.12.031. Epub 2014 Feb 19.</citation>
    <PMID>24559784</PMID>
  </reference>
  <reference>
    <citation>Chen YK, Pleskow DK. SpyGlass single-operator peroral cholangiopancreatoscopy system for the diagnosis and therapy of bile-duct disorders: a clinical feasibility study (with video). Gastrointest Endosc. 2007 May;65(6):832-41.</citation>
    <PMID>17466202</PMID>
  </reference>
  <reference>
    <citation>Draganov PV, Lin T, Chauhan S, Wagh MS, Hou W, Forsmark CE. Prospective evaluation of the clinical utility of ERCP-guided cholangiopancreatoscopy with a new direct visualization system. Gastrointest Endosc. 2011 May;73(5):971-9. doi: 10.1016/j.gie.2011.01.003. Epub 2011 Mar 17.</citation>
    <PMID>21419408</PMID>
  </reference>
  <reference>
    <citation>Chen YK, Parsi MA, Binmoeller KF, Hawes RH, Pleskow DK, Slivka A, Haluszka O, Petersen BT, Sherman S, Devière J, Meisner S, Stevens PD, Costamagna G, Ponchon T, Peetermans JA, Neuhaus H. Single-operator cholangioscopy in patients requiring evaluation of bile duct disease or therapy of biliary stones (with videos). Gastrointest Endosc. 2011 Oct;74(4):805-14. doi: 10.1016/j.gie.2011.04.016. Epub 2011 Jul 18.</citation>
    <PMID>21762903</PMID>
  </reference>
  <reference>
    <citation>Ramchandani M, Reddy DN, Gupta R, Lakhtakia S, Tandan M, Darisetty S, Sekaran A, Rao GV. Role of single-operator peroral cholangioscopy in the diagnosis of indeterminate biliary lesions: a single-center, prospective study. Gastrointest Endosc. 2011 Sep;74(3):511-9. doi: 10.1016/j.gie.2011.04.034. Epub 2011 Jul 7.</citation>
    <PMID>21737076</PMID>
  </reference>
  <reference>
    <citation>Siddiqui AA, Mehendiratta V, Jackson W, Loren DE, Kowalski TE, Eloubeidi MA. Identification of cholangiocarcinoma by using the Spyglass Spyscope system for peroral cholangioscopy and biopsy collection. Clin Gastroenterol Hepatol. 2012 May;10(5):466-71; quiz e48. doi: 10.1016/j.cgh.2011.12.021. Epub 2011 Dec 16.</citation>
    <PMID>22178463</PMID>
  </reference>
  <verification_date>July 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 22, 2015</study_first_submitted>
  <study_first_submitted_qc>November 23, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 26, 2015</study_first_posted>
  <last_update_submitted>July 26, 2017</last_update_submitted>
  <last_update_submitted_qc>July 26, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">July 31, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Biliary Tract Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

